Get the tools used by (smart)2 investors.

Upside (Analyst Target) for AstraZeneca

Join now and get access to the full platform

Search for company or ETF

 

  0 results available. Select is focused ,type to refine list, press Down to open the menu,

ZEG: AstraZeneca

AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacture, and commercialization of prescription medicines. The company offers Imjudo, Datroway, Iressa, Tagrisso...

134.80 EUR
Price
EUR
Fair Value
Upside
117.05 - 158.15
52-week range

Analysis

How does AstraZeneca's Upside (Analyst Target) benchmark against competitors?

Hide this widget

We've identified the following companies as similar to AstraZeneca because they operate in a related industry or sector. We also considered size, growth, and various financial metrics to narrow down the list to the ones listed below.

Metric Usage: Upside (Analyst Target)

Hide this widget
analyst_target_upside
Slug
number
Datatype
text
Format
current
Default Period
FY, LTM
Periods Supported
Free
Plan

To view the full list of supported financial metrics please see Complete Metrics Listing.

Similar Metrics

Hide this widget

Metrics similar to Upside (Analyst Target) in the predictions category include:

View Full List

Search for metric or datapoint

Upside (Analyst Target)

The percentage increase (if positive) or decrease (if negative) that professional analysts expect over the current stock price.

Definition of Upside (Analyst Target)

Hide this widget

Upside (Analyst Target) is the percentage increase (if positive) or decrease (if negative) that professional analysts expect over the current stock price. Downside (Analyst Target) is the inverse of this metric.


    Upside = (Analyst Price Target / Stock Price) - 1

Sector Benchmark Analysis

Sector
Industry Group
Industry
Hide this widget
0.0%1,500.0%4,299.3%0200400600

The chart above depicts the distribution of upside (analyst target) for companies operating in the Healthcare sector in the Developed economic region. Over 1,500 companies were considered in this analysis, and 1,441 had meaningful values. The average upside (analyst target) of companies in the sector is 286.5% with a standard deviation of 475.0%.

AstraZeneca's Upside (Analyst Target) of NM ranks in the - percentile for the sector. The following table provides additional summary stats:

Upside (Analyst Target) In The Healthcare Sector
Economic Risk RegionDeveloped
Total Constituents1,501
Included Constituents1,441
Min-2.3%
Max4,282.3%
Median113.8%
Mean286.5%
Standard Deviation475.0%

You can find companies with similar upside (analyst target) using this stock screener.

All rights reserved. Terms Of Use